Anti-CD30 CAR T cells
WHUH-CART-CD30-01
Phase 1 gene_therapy active
Quick answer
Anti-CD30 CAR T cells for Adult T-Cell Lymphoma/Leukaemia is a Phase 1 program (gene_therapy) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Adult T-Cell Lymphoma/Leukaemia
- Phase
- Phase 1
- Modality
- gene_therapy
- Status
- active